NASDAQ:SXTC | Free Cash Flow | China SXT Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.02M
2025-03-31-$2.35M$2,023.00-$2.35M
2024-03-31-$1.93M$7,063.00-$1.94M
2023-03-31-$80,757.00
2022-03-31$268,293.00
2021-03-31-$1.32M
2020-03-31$934,247.00$130,839.00$803,408.00
2019-03-31$239,192.00$535,825.00-$296,633.00-19.27%
2018-03-31$1.92M$436,017.00$1.48M124.97%
2017-03-31$293,042.00$179,176.00$113,866.009.61%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.